Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Lancet Infect Dis. 2015 Jun 17;15(8):889–897. doi: 10.1016/S1473-3099(15)00093-6

Figure 1. Trial profile.

Figure 1

tOPV=trivalent oral polio vaccine. mOPV1=monovalent oral polio vaccine type 1. bOPV=bivalent OPV type 1 and 3. SIA=supplementary immunisation activity.